most patients with type iii hyperlipoproteinemia have a structural defect in apolipoprotein e associated with increased synthesis and decreased catabolism of apolipoprotein e , delayed catabolism of chylomicron remnants , and development of plasma lipoprotein abnormalities characteristic of type iii hyperlipoproteinemia .
C0003595
apolipoprotein e
C0023820
lipoprotein